CAPITAL STOCK (Details)							1 Months Ended	12 Months Ended
	Jan. 13, 2021 USD ($) $ / shares shares	Dec. 10, 2020 USD ($)	Dec. 09, 2020 USD ($)	Oct. 07, 2020 USD ($) $ / shares shares	Nov. 15, 2019 $ / shares shares	Oct. 31, 2019	Dec. 31, 2018 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2020 USD ($) $ / shares shares	Sep. 16, 2020 shares	Sep. 15, 2020 shares	Nov. 01, 2019 $ / shares
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Reverse stock split						0.025
Common stock, par value | $ / shares								$ 0.001	$ 0.001			$ 0.001
Common stock, shares authorized								200,000,000	200,000,000	200,000,000	500,000,000
Total Gross Proceeds | $								$ 13,756,507	$ 0
Number of warrants outstanding								745,268	1,038,919
Number of warrants exercised								520,151
Net proceeds from exercise of warrants | $		$ 1,100,000	$ 1,100,000					$ 2,613,929	$ 8,055,797
Public Offering
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Common stock issued in private placement, net of offering costs (in shares)	1,810,000				2,285,000
Number of common stock called by warrants					2,285,000
Number of common shares that each warrant has right to purchase					1
Exercise price of warrants (in dollars per share) | $ / shares				$ 5.25	$ 5.25		$ 5.60
Public offering price for each share together with warrant | $ / shares	$ 8.30				$ 5.25
Additional number of common stock called by warrants					342,750
Number of warrants outstanding							8,375
Incremental change in fair value of warrants | $							$ 2,842
Number of warrants exercised				318,000				520,151	1,649,786
Net proceeds of offering after underwriter discounts, commissions and other offering expenses | $	$ 13,800,000
Net proceeds from exercise of warrants | $				$ 1,669,500				$ 2,700,000	$ 8,100,000